Sequana Medical, a specialist in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, has announced the successful completion of the first commercial implantation of the alfapump System in the United States. This is a key milestone in Sequana Medical’s U.S comme
Developer of transformative implants Xeltis has announced that it has secured nearly 50m EUR of new financing, consisting of up to 37.5m EUR from the EIB, supported under the European Commission’s Invest EU programme, and 10m EUR from existing investors, including EQT, investing from its LSP Health
Medtronic has announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The Hugo RAS system’s clearance brings a versatile robotic-assisted platform to U.S. surgeons and health systems seeking to expand s
Diagnostics company Neuro Event Labs Oy (NEL) has announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for clinical use of its Nelli Seizure Monitoring System in the hospital setting. Nelli, recognised by the FDA as a Breakthrough Device, is the world’s first non-c
NHS Supply Chain is supporting the NHS to treat cancer patients quicker with the supply of 28 ‘cutting edge’ new linear accelerator (LINAC) radiotherapy systems in 2025/26 to NHS cancer centres across the country. The rollout of the new technology is backed by centralised government funding provided
Martin Murphy, Principal Consultant at 42 Technology explains what impact the FDA’s upcoming new regulation will have on drug delivery device developers. The regulatory world of medical devices is undergoing one of the most significant transformations in nearly three decades. The long-standing Quali
Editor Oli Johnson speaks to HiArc President Nate Doemling about the role the company plays in product development for life sciences companies, offering a tactical guide on avoiding common design and regulatory missteps. Earlier this year, HiArc rebranded from its previous name, KMC Systems, as the
The UK has just seen the first case of treatment for benign prostatic hyperplasia (BPH) with Rezūm Water Vapour Therapy using the newly launched Rezūm EVO Console at Basingstoke and North Hampshire Hospital. BPH is a non-malignant condition which causes an urgent need to urinate, difficulty starting
UK-based charity Keep Me Breathing (KMB) has unveiled VENTO, a breakthrough non-invasive wearable CO2 monitor that it says marks a major step forward in respiratory technology for people born with Congenital Central Hypoventilation Syndrome (CCHS) and other rare breathing disorders. KMB says that VE
Elizabeth Norwood, Senior Chemist at MicroCare, LLC, outlines the impact of contamination on optical signal transmission, the role of electrostatic attraction in persistent debris, and the importance of adopting industry-approved inspection and cleaning standards like IEC 61300-3-35. Norwood advocat
Editor Oli Johnson caught up with Ensera CEO Jason Anderson at COMPAMED 2025 to talk about the brand transformation and the new direction Ensera is taking, as well as the company’s role in the Neupulse device.
Editor Oli Johnson spoke to Dennis Gavranovich and Caroline Herdman of Junkosha about the company’s newly-launched dual layer hybrid channel tubing at COMPAMED 2025.
